These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 29982331)

  • 61. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
    Xu M; Li Q; Zhang J; Xie H
    Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
    Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
    Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A six-long non-coding RNA signature predicts prognosis in melanoma patients.
    Yang S; Xu J; Zeng X
    Int J Oncol; 2018 Apr; 52(4):1178-1188. PubMed ID: 29436619
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
    Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
    Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A prognostic 10-lncRNA expression signature for predicting the risk of tumour recurrence in breast cancer patients.
    Tang J; Ren J; Cui Q; Zhang D; Kong D; Liao X; Lu M; Gong Y; Wu G
    J Cell Mol Med; 2019 Oct; 23(10):6775-6784. PubMed ID: 31429520
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
    Zhang X; Zhang M; Zhang X; Zhu X; Wang J
    BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A novel seven-long non-coding RNA signature predicts survival in early stage lung adenocarcinoma.
    Chen M; Liu B; Xiao J; Yang Y; Zhang Y
    Oncotarget; 2017 Feb; 8(9):14876-14886. PubMed ID: 28122330
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of Potential Prognostic Long Non-Coding RNA Biomarkers for Predicting Survival in Patients with Hepatocellular Carcinoma.
    Liao X; Yang C; Huang R; Han C; Yu T; Huang K; Liu X; Yu L; Zhu G; Su H; Wang X; Qin W; Deng J; Zeng X; Ye X; Peng T
    Cell Physiol Biochem; 2018; 48(5):1854-1869. PubMed ID: 30092592
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer.
    Wu B; Wang K; Fei J; Bao Y; Wang X; Song Z; Chen F; Gao J; Zhong Z
    Oncol Rep; 2018 Dec; 40(6):3427-3437. PubMed ID: 30542694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
    Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
    Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer.
    Liu B; Li X; Li J; Jin H; Jia H; Ge X
    Dis Markers; 2020; 2020():8860788. PubMed ID: 33101546
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer.
    Qu A; Wang Q; Chang Q; Liu J; Yang Y; Zhang X; Zhang Y; Zhang X; Wang H; Zhang Y
    Sci Rep; 2023 Jan; 13(1):1350. PubMed ID: 36693876
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fifteen-MiRNA-Based Signature Is a Reliable Prognosis-Predicting Tool for Prostate Cancer Patients.
    Bian Z; Huang X; Chen Y; Meng J; Feng X; Zhang M; Zhang L; Zhou J; Liang C
    Int J Med Sci; 2021; 18(1):284-294. PubMed ID: 33390797
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Wang P; Zeng Z; Shen X; Tian X; Ye Q
    DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.
    Zeng H; Wu H; Yan M; Tang L; Guo X; Zhao X
    Leuk Res; 2020 Jan; 88():106261. PubMed ID: 31739140
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
    Zhao C; Zou H; Wang J; Shen J; Liu H
    DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor microenvironment derived signature predicting relapse-free survival in I-III cancer and preliminary experiment verification.
    Zhang Z; Wu Q; Zhu D; He G; Feng Q; Xu J
    Int Immunopharmacol; 2021 Feb; 91():107243. PubMed ID: 33321467
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.
    Li J; Chen Z; Tian L; Zhou C; He MY; Gao Y; Wang S; Zhou F; Shi S; Feng X; Sun N; Liu Z; Skogerboe G; Dong J; Yao R; Zhao Y; Sun J; Zhang B; Yu Y; Shi X; Luo M; Shao K; Li N; Qiu B; Tan F; Chen R; He J
    Gut; 2014 Nov; 63(11):1700-10. PubMed ID: 24522499
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of Prognostic Indicator Based on Autophagy-Related lncRNA Analysis in Colon Adenocarcinoma.
    Zhou W; Zhang S; Li HB; Cai Z; Tang S; Chen LX; Lang JY; Chen Z; Chen XL
    Biomed Res Int; 2020; 2020():9807918. PubMed ID: 32964050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.